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CollagenVI mutations lead to disabling myopathies like Bethlem myopathy (BM) and Ullrich
congenital muscular dystrophy (UCMD). We have investigated the nutritional and meta-
bolic status of one UCMD and seven BM patients (five female, three male, mean age
31±9 years) in order to find a potential metabolic target for nutritional intervention. For this
study, we used standard anthropometric tools, such as BMI evaluation and body circum-
ference measurements. All results were compared to dual-energy X-ray absorptiometry
(DXA), considered the “gold standard” method. Energy intake of each patient was eval-
uated through longitudinal methods (7-day food diary) while resting energy expenditure
(REE) was predicted using specific equations and measured by indirect calorimetry. Clinical
evaluation included general and nutritional blood and urine laboratory analyses and quanti-
tative muscle strength measurement by hand-held dynamometry. BM and UCMD patients
showed an altered body composition, characterized by low free fat mass (FFM) and high fat
mass (FM), allowing us to classify them as sarcopenic, and all but one as sarcopenic-obese.
Another main result was the negative correlation between REE/FFM ratio (basal energy
expenditure per kilograms of fat-free mass) and the severity of the disease, as defined by
the muscle megascore (correlation coefficient −0.955, P -value <0.001). We postulate that
the increase of the REE/FFM ratio in relation to the severity of the disease may be due
to an altered and pathophysiological loss of energetic efficiency at the expense of skeletal
muscle. We show that a specific metabolic disequilibrium is related to the severity of the
disease, which may represent a target for a nutritional intervention in these patients.
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INTRODUCTION
Mutations in the genes COL6A1, COL6A2, and COL6A3, cod-
ing for three α chains of collagen type VI, cause COL6-related
myopathies (COL6-RM), including the severe Ullrich congeni-
tal muscular dystrophy (UCMD), the milder Bethlem myopathy
(BM) (Bertini and Pepe, 2002; Allamand et al., 2010), and the
Myosclerosis Myopathy in a single family (Merlini et al., 2008a,b).
The prevalence of UCMD and BM has been calculated as 0.13
per 100,000 and 0.77 per 100,000, respectively (Norwood et al.,
2009). BM (MIM #158810) (Merlini et al., 1994) is characterized
by axial and proximal muscle wasting and weakness with finger
flexion contractures. BM is usually mild, sometimes slowly pro-
gressive (Pepe et al., 2002). BM has both dominant and recessive
inheritance (Gualandi et al., 2009). Immunohistochemistry shows
normal or mildly reduced levels of ColVI in the endomysium of
most BM patients (Allamand et al., 2010). UCMD (MIM #254090)
(Mercuri et al., 2005) is a severe congenital muscular dystrophy,
characterized by early onset, generalized and rapidly progressive
muscle wasting and weakness, proximal joint contractures, and
distal joint hypermobility. Walking ability is rarely achieved or
preserved during adolescence, and the rapid progression of the
clinical symptoms usually leads to early death, due to respiratory
failure (Mercuri et al., 2005). UCMD is caused both by recessive
and de novo dominant mutations (Mercuri et al., 2005). ColVI
appears to be strongly reduced or absent in muscle biopsies from
UCMD patients.
A dystrophic mouse model, where collagen VI synthesis was
prevented by targeted inactivation of the Col6a1 gene, allowed
the investigation of the pathogenesis, revealing the existence of a
Ca(2+)-mediated dysfunction of the mitochondria and sarcoplas-
mic reticulum and defective autophagy (Bernardi and Bonaldo,
2013). Similar defects contribute to the disease pathogenesis in
patients, irrespective of the genetic lesion causing the collagen
VI defect (Irwin et al., 2003; Grumati et al., 2010). These studies
indicate that permeability transition pore opening and defective
autophagy represent key elements of skeletal muscle fiber death,
and provide a rationale for the use of cyclosporin A (Merlini
et al., 2008a,b) and of nutritional interventions to correct defective
autophagy (Merlini et al., 2014) in patients affected by COL6-RM,
a strategy that holds great promise for treatment.
In the last decade, several studies have demonstrated that nutri-
tional status and body composition are strictly related to clinical
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outcomes and that nutritional intervention can be effective in the
prevention and treatment of many diseases related to metabolism,
bioenergetics, and even cancer.
According to a three-compartment model of body composi-
tion (Moon et al., 2008), total body weight is the sum of lean mass
(LM), fat mass (FM), and bone mineral content (BMC). The LM,
which includes the mass of the internal organs and that of the
muscles, together with the BMC, form the fat-free mass (FFM),
which represents the more metabolically active component of the
human body. A “pathological” ratio between FFM and FM and/or
an abnormal distribution of these components in the body, mainly
trunk versus appendages, is found in many pathological conditions
and correlates with the severity of the metabolic or energy status
alteration; moreover, modifications of body composition per se
may represent an independent health risk factor (Wohlfahrt et al.,
2014). Augmented FM leads to a higher cardiometabolic risk and
to a higher incidence of hypertension, diabetes (Rohan et al., 2013),
and cardiovascular diseases.
Muscular dystrophies (MD) are characterized by progressive
deterioration of muscle mass, muscle strength, and function. Rest-
ing energy expenditure (REE), which comprises 70% of daily
energy needs, is determined by the amount and composition of
the metabolically active fat-free mass (FFM). The reduced muscle
mass and muscular activity, characteristic of MDs, could result in
a significant parallel decrease in REE. Surprisingly, it was found
that that patients with Emery-Dreifuss MD (Vaisman et al., 2004)
and Duchenne and Becker MD (Zanardi et al., 2003a; Gonzalez-
Bermejo et al., 2005; Hogan, 2008; Elliott et al., 2012) may have
increased energy expenditure. If not met with increased caloric
intake, this greater energy expenditure may partially contribute to
further deterioration in their muscle mass and function.
It has already been shown that patients with COL6-RM have
reduced muscle mass, muscle strength, and muscle function (Mis-
cione et al., 2013). To date, no data are available on the energy
expenditure in COL6-RM. The aim of this study is to investi-
gate the relationship between REE, body composition, and muscle
strength in COL6-RM.
MATERIALS AND METHODS
PATIENTS
We analyzed eight adult patients (five women, three men, mean age
31± 9 years) with COL6-RM: seven had BM and one UCMD. The
UCMD patient was never able to walk and was on nocturnal non-
invasive mechanical ventilation. This study was approved by the
institutional ethical committee of the Istituto Ortopedico Rizzoli
(ClinicalTrials.gov identifier: NCT01438788). All subjects were
fully informed about the study and gave their written informed
consent.
BODY COMPOSITION
Nutritional status was evaluated throughout the study by both
non-invasive and invasive techniques (El Ghoch et al., 2014). Body
composition was obtained by DXA (Hologic 4500 W; software
version 11.2; Hologic, Inc., Waltham, MA, USA) software, which
provides regional and whole-body estimation of LM, FM, and
BMC, according to the three-compartment model of body com-
position. FFM was calculated as the sum of LM and BMC, and has
been provided for each body part (i.e., trunk and limbs) (Scaglioni
et al., 2013). From these whole-body measures, the following
derivative values were calculated: FMI (FM/height2), LM/height2,
appendicular lean mass/height2 (ALMI). Appendicular lean mass
(ALM) was the sum of bone-free and fat-free tissue masses in the
arms and legs. Sarcopenic obesity was defined, according to Baum-
gartner et al. (2004), as ALM divided by stature squared (ALMI)
less than 7.26 kg/m2 in men and 5.45 kg/m2 in women and per-
centage body fat, derived by DXA, greater than 28% in men and
40% in women (Baumgartner et al., 2004).
Anthropometric measurements included: body weight (Wt),
height (Ht), and circumferences [waist, hip, waist-hip ratio
(WHR)]. All measurements were determined by the same operator
following the Anthropometric Standardization Reference Manual
recommendations (Lohman et al., 1988). Body mass index (BMI)
was calculated as Wt [Kg/Ht(m2)]. We used BMI to categorized
participants as obese (BMI ≥30), overweight (25≤BMI< 30),
normal weight (18.5<BMI< 25), or underweight ≤18.5.
ENERGY AND NITROGEN BALANCE
Resting energy expenditure was estimated by indirect calorimetry
using a metabolic measurement cart with a canopy hood (CareFu-
sion Vmax Encore, San Diego, CA, USA). Subjects were instructed
to fast for 12 h and abstain from exercise for 24 h before the test
(Mifflin et al., 1990). Before measuring REE, all subjects were asked
to rest quietly in the supine position for approximately 30–40 min
in an isolated room, with a temperature between 21° and 24°C. The
criterion for a valid REE was 15 min of steady state, determined as
<5% variation in respiratory quotient (RQ)/minute and oxygen
consumption/minute. Oxygen consumption and carbon dioxide
production were used to calculate REE, in accordance with the
Weir equation (Turell and Alexander, 1964). REE were also cal-
culated with the equations based on weight, height, age, and sex
[Harris-Benedict and Schofield (Energy and protein requirements.
Report of a joint FAO/WHO/UNU expert consultation, 1985; Roza
and Shizgal, 1984)] using the free fat mass (FFM)-based predictive
equations of Mifflin and Katch and McArdle (McArdle et al., 1986;
Mifflin et al., 1990).
Food intake was evaluated by a 7-day food diary and a dietitian
interview (O’Connor et al., 2014). Nitrogen balance, an important
tool for estimating adequate protein intake (Tarnopolsky et al.,
1988), was calculated as the difference between nitrogen input
(24 h dietary protein intake) and nitrogen output (24 h urinary
urea nitrogen).
General and nutritional blood and urine laboratory analyses
(albumin: transferrin; creatinine; uric acid; glucose; triglycerides:
total, HDL, and LDL cholesterol; urinary creatinine; and nitrogen)
were taken to assess the metabolic status of the patients. The 24-h
urinary creatinine excretion value was used as an index of protein
nutrition; the creatinine height index (CHI) and lean body mass
was estimated from this value.
MUSCLE STRENGTH
A composite score (megascore) was calculated by summing the
maximal force of eight physical tests (Bryan et al., 2003; Merlini
et al., 2003) using a hand-held dynamometer (Type CT 3001, Citec,
C.I.T. Technics BV, Groningen, The Netherlands) (Van der Ploeg
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et al., 1991; Beenakker et al., 2001). Four muscle groups were exam-
ined bilaterally: hand grip, elbow flexors, knee extensors, and knee
flexors (Merlini et al., 2002, 2003, 2004). Each individual muscle
group was tested for at least 3 s using a “make” test (Merlini et al.,
2004). The maximum force from three attempts was used in the
analysis.
STATISTIC ANALYSIS
Pearson correlation coefficients were calculated to study the asso-
ciation between different parameters. Statistical significance was
set at 0.05. All analyses were conducted using the STATA software
package for Windows 13.1 (Stata Corp, College Station, TX, USA).
Measurable variables are presented as mean± SD and categorical
data as number and percentage.
RESULTS
ANTHROPOMETRIC EVALUATION
Anthropometric analysis showed that UCMD and BM patients
have average BMI values in the range of normality, comparable
with a healthy population (Janssen et al., 2002). Body circumfer-
ence measurements do not show any significant variations from
normality (Janssen et al., 2002) (Table 1).
BODY COMPOSITION ANALYSIS
Body composition analysis showed quantitative changes in all the
partitions of the body. All the patients had a loss of muscle mass,
as shown by a marked reduction of FFM, FFMI, and ALMI, and
augmented FM, as indicated by % FM and FMI.
In particular, all patients were sarcopenic, based on ALMI, and
seven were sarcopenic-obese, based on ALMI and % FM (Tables 2
and 3).
Table 1 | Anthropometric analysis.
M (n=3) W (n=5)
Body weight (Kg) 67.40 61.24
(±11.39) (±12.34)
Body height (m) 1.72 1.63
(±0.01) (±0.05)
BMI (Kg/m2) 22.73 23.05
(±3.72) (±4.25)
(N.V. 18.5–24.9) (N.V. 18.5–24.9)
Waist circumference (cm) 83.83 74.85
(±8.78) (±7.19)
(N.V. <94) (N.V. <80)
Hip circumference (cm) 96.83 103.13
(±6.25) (±13.24)
waist-hip ratio (WHR) 0.86 0.72
(±0.05) (±0.05)
(N.V. <1) (N.V. <0.85)
The table shows the values obtained from the standard anthropometric analysis.
For each parameter, the mean values±SD are presented.When possible, normal
values (N.V.) were reported (M, men andW, women).
Moreover, from the DXA data (trunk-to-limb FM ratio) and
anthropometric parameters (waist circumference and waist/hip
ratio index), we can deduce that, in the two compartments, the
increased fat tissue was equally distributed (DXA) compensating
for the loss of muscle mass (circumferences).
Bone mineral content, the other component of the FFM, is also
strongly reduced in these patients, especially in men. The data are
confirmed by T -score calculations in our male patients (Male T -
score −1.87). T -score is a diagnostic for osteopenia (Kanis et al.,
2013) (Tables 2 and 3).
BLOOD, URINE BIOCHEMICAL ANALYSIS, AND NITROGEN BALANCE
Blood and urine analysis do not show any specific pathological
modification. In particular, although seven out of eight patients
were obese, according to % fat determined by DXA, none had
high levels of blood triglycerides, total cholesterol, HDL, or
LDL (Jukema and Simoons, 1999). Blood creatinine levels were
Table 2 | Dual-energy X-ray absorptiometry.
M (n=3) W (n=5)
Fat-free mass (FFM) (%) 62.03 48.36
(±18.19) (±6.55)
Fat-free mass (FFM) (Kg) 42.39 29.22
(±4.08) (±3.53)
FFMI (FFM/height2) (Kg/m2) 14.43 10.90
(±1.27) (±0.85)
Fat mass (FM) (%) 34.63 51.64
(±14.21) (±6.55)
Fat mass (FM) (Kg) 23.86 31.93
(±12.05) (±9.76)
FMI (FM/height2) (Kg/m2) 8.18 12.07
(±4.20) (±3.71)
Bone mineral content (BMC) (%) 3.16 3.06
(±0.61) (±0.84)
Bone mineral content (BMC) (Kg) 2.08 1.82
(±0.04) (±0.36)
T -score −1.87 −0.23
(±0.49) (±0.86)
Trunk-to-limb fat mass ratio 1.10 0.82
(±0.03) (±0.06)
ALMI (Kg/m2) 5.68 4.25
(±0.57) (±1.43)
ALM (Kg) 9.79 6.92
(±1.01) (±2.35)
Trunk lean mass (Kg) 21.35 14.66
(±2.24) (±1.12)
Trunk fat mass (Kg) 11.85 13.70
(±6.13) (±5.11)
The table shows DXA body composition values. Mean values±SD are presented
(M, men andW,Women).
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Table 3 | Body composition values obtained by anthropometric and DXA analyses, in BM and UCMD patients, compared to a healthy population.
ID Sex Age (years) BMI (Kg/m2) Fat % FFM% BFMI (Kg/m2) Trunk to limbs
FM ratio
ALMI
(Kg/m2)
Pt. 1 W 48 20.9 49.90↑ 50.1↓ 10.10↓ 0.88↓ 3.60↓
N.V. (18.5–24.9) N.V. (39.8–40.8) N.V. (59.2–60.2) N.V. (10.72–11.20) N.V. (0.92–0.947) N.V. (6.93–6.9)
Pt. 2 W 19 22.10 53.50↑ 46.5↓ 11.80↑ 0.83↑ 3.48↓
N.V. (18.5–24.9) N.V. (35.1) N.V. (64.8) N.V. (8.48) N.V. (0.745) N.V. (6.81)
Pt. 3 W 42 18.19 41.30↑ 58.7↓ 7.53↓ 0.80↓ 3.81↓
N.V. (18.5–24.9) N.V. (38.9–39.8) N.V. (60.2–62.1) N.V. (10.27–10.72) N.V. (0.897–0.920) N.V. (6.95–6.93)
Pt. 4 W 29 24.60 55.00↑ 45↓ 13.50↑ 0.86↑ 4.94↓
N.V. (18.5–24.9) N.V. (36–37) N.V. (63–64) N.V. (8.9–9.35) N.V. (0.796–0.841) N.V. (6.86–6.9)
Pt. 5 W 22 29.44 58.50↑ 41.5↓ 17.40↑ 0.73↓ 4.93↓
N.V. (18.5–24.9) N.V. (35.1–36) N.V. (64–64.9) N.V. (8.48–8.9) N.V. (0.745–0.796) N.V. (6.81–6.86)
Pt. 6 M 36 23.29 44.20↑ 45.8↓ 10.30↑ 1.14↑ 5.05↓
N.V. (18.5–24.9) N.V. (26.6–27.5) N.V. (72.5–73.4) N.V. (7.19–7.57) N.V. (1.125–1.183) N.V. (9.09–9.12)
Pt. 7 M 27 18.76 18.30↓ 81.7↑ 3.34↓ 1.15↑ 6.35↓
N.V. (18.5–24.9) N.V. (24.60–25.70) N.V. (74.3–75.4) N.V. (6.37–6.78) N.V. (0.995–1.063) N.V. (8.94–9.02)
Pt. 8 M 28 26.13 41.40↑ 58.6↓ 10.90↑ 1.08↑ 5.81↓
N.V. (18.5–24.9) N.V. (24.60–25.70) N.V. (74.3–75.4) N.V. (6.37–6.78) N.V. (0.995–1.063) N.V. (8.94–9.02)
The table shows the body composition values of our subjects (M, men and F, women) compared to healthy values reported in the literature (Kelly et al., 2009;Wang
et al., 2010). We used: “↑” when the values were increased; “↓”when the values were low.
moderately decreased (Ballesteros et al., 1994), particularly in
women. Urinary creatine levels were generally low, particularly
in men. Consequently, calculated CHI, an index of muscle mass
(Rosenfalck et al., 1994), was greatly reduced in UCMD and BM
patients.
Nitrogen balance was in the normal range.
Moreover, megascore values in our patients reflect the low
strength condition typical of MDs (Table 4).
RESTING ENERGY EXPENDITURE AND RESPIRATORY QUOTIENT
Resting energy expenditure was measured by indirect calorime-
try and estimated by specific predictive equations. The REEs
estimated by the equations based on weight, height, age,
and sex accurately predicted the same values measured with
indirect calorimetry [Harris-Benedict and Schofield (“Energy
and protein requirements. Report of a joint FAO/WHO/UNU
Expert Consultation,” 1985; Roza and Shizgal, 1984)]. REE
was instead severely underestimated using the FFM-based pre-
dictive equations of Mifflin and Katch and McArdle (McAr-
dle et al., 1986; Mifflin et al., 1990). Hence, considering that
these patients are characterized by a reduced FFM in kilo-
grams, we can deduce that there is a relative hypermetabolic
state (Müller, 2007) with a higher ratio of REE (kcal)/FFM (kg)
(Figure 1).
Measured RQs values are indicative of a mixed nutrient-based
metabolism. However, there was a sex difference concerning the
type of substrates utilized. While male patients had a higher
carbohydrate-based metabolism (57.67± 14.57% carbohydrates),
women showed a higher lipid-based metabolism (56.00± 16.39%
lipids) (Table 5) (Figure 2). There was a strong positive corre-
lation between the quantity of FFM in kg and the percentage of
carbohydrates metabolized during REE. This correlation, however,
was negative for the percentage of lipids metabolized. No corre-
lation was found between the percentage of proteins used as a
metabolic substrate and FFM.
All in all, patients are characterized by an augmented REE per
kilogram of FFM; additionally, subjects with higher FFM values
metabolize more carbohydrates and less lipids then the ones with
minor FFM levels (Figure 3).
MUSCLE STRENGTH
Megascores expressed as the sum of the muscle strength of eight
different tests, were 1093.33 (±306.37) Newton in men and 572.60
(±233.11) in women. These values were markedly reduced, as
muscle strength was low in all muscle groups, compared with the
normative values (Van der Ploeg et al., 1991; Beenakker et al.,
2001).
There was a strong correlation between muscle strength,
expressed as Megascore, and the various indices of muscle mass,
but no correlation with the indices of body fat. A strong correla-
tion was found between Megascore and blood creatinine. This
correlation was even stronger with urinary creatinine and the
derived index “CHI” (Figure 6). UCMD and BM patients who
had a higher FFM showed a better performance in the muscle
strength tests. The Megascore was directly proportional to FFM
in kilograms and inversely proportional to the REE/FFM ratio
(Figure 4).
This trend is maintained in the correlation between the Megas-
core and both trunk and limbs FFM. However, the linear correla-
tion coefficient was higher between Megascore and appendicular
FFM than Megascore and Trunk FFM (Figure 5). FFM% also
correlated with Megascore, but the correlation was weaker.
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Table 4 | Clinical and laboratory data.
Men (n=3) Women (n=5)
Creatinine (mg/dL) 0.64 0.26
(±0.30) (±0.07)
N.V. (0.8–1.3) N.V. (0.6–1.1)
Urinary creatinine (mg/24 h) 893.33 394.00
(±347.04) (±107.84)
N.V. (500–2000) N.V. (500–2000)
Creatinine height index (CHI) (%) 57.63 39.19
(±22.45) (±10.83)
N.V. (109) N.V. (110)
Dietary CHO intake (g) 342.56 197.62
(±48.17) (±62.38)
Dietary lipid intake (g) 89.05 63.62
(±27.47)0 (±27.55)
Dietary protein intake (g) 83.58 68.12
(±8.90) (±26.02)
Nitrogen intake (g) 13.37 10.90
(±1.42) (±4.16)
Urinary urea nitrogen (g) 13.04 11.99
(±1.08) (±3.48)
Nitrogen balance −0.67 −1.84
(±1.67) (±1.30
N.V. (0.00) N.V. (0.00)
Megascore 1093.33 572.60
(±306.37) (±233.11)
The table shows the biochemical values obtained from blood and urine analysis
and Megascore (Merlini et al., 2002, 2004). For each parameter, the mean val-
ues±SD are presented. When possible, normal values (N.V.) were reported (M,
men andW, women).
FIGURE 1 | Predicted and measured REE in UCMD and BM patients
grouped by sex. Mean REE measured with indirect calorimetry (black
rectangles); REE estimated with FFM-based Mifflin equation (Mifflin et al.,
1990) (white rectangles) or Harris-Benedict) revised equation (Roza and
Shizgal, 1984) (gray rectangles).
No correlation was found any between the Megascore and the
indices of fat mas, FM in kilograms, FM percentage, or REE/FM
ratio.
Table 5 | Energy balance.
M (n=3) W (n=5)
REE indirect calorimetry (Kcal) 1508.33 1315.02
(±120.03) (±107.55)
REE Mifflin et Al (Kcal) 1248.09 988.67
(±80.28) (±69.62)
REE Katch and McArdle (Kcal) 1285.63 1001.19
(±88.02) (±76.34)
REE FAO Schofield et al. (Kcal) 1708.48 1392.91
(±175.28) (±173.51)
REE Harris-Benedict 1984 (Kcal) 1645.34 1412.83
(±152.67) (±159.62)
Mifflin FFM/REE 76.25 70.36
Indirect calorimetry % (±8.28) (±5.20)
FAO/REE indirect calorimetry % 113.15 106.35
(±4.14) (±15.14)
Harris-Benedict 1984/REE 109.01 107.88
Indirect calorimetry % (±1.71) (±14.32)
Respiratory quotient (RQ) 0.90 0.80
(±0.06) (±0.03)
RQ proteins (%) 19.67 20.00
(±2.89) (±9.89)
RQ lipids (%) 22.33 56.00
(±17.95) (±16.39)
RQ carbohydrates (%) 57.67 23.75
(±14.57) (±7.45)
REE/FFM (Kcal/Kg) 35.77 45.46
(±3.92) (±6.13)
REE/FM (Kcal/Kg) 80.61 44.54
(±51.94) (±13.75)
In this table, values of indirect calorimetry and predictive equations analysis are
presented. For each parameter, the mean values±SD are presented (M, men
andW, women).
DISCUSSION
In this study, we have investigated the relationship between body
composition, energetic metabolism, and muscle strength in a
cohort of patients with COL6-RM.
According to body composition, evaluated by DXA, all patients
could be defined as sarcopenic and all but one as sarcopenic-
obese. The patients showed a marked increment of the amount
of FM and a severe loss of FFM without important modifica-
tions in the BMI, which ranged from underweight to overweight,
or in waist circumferences measures, which were within a nor-
mal range. This peculiar modification in body composition can
be explained by the process of fatty infiltration of the muscle in
MD (Tuffery-Giraud et al., 2004; Jarraya et al., 2012; Willis et al.,
2014).
Since FFM is the major determinant of energy expenditure in
normal subjects, we integrated body composition analysis with
the analysis of energy status and of muscle strength in accordance
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FIGURE 2 | UCMD and BM patients’ metabolism. Percentage of
Carbohydrates (CHO), Lipids (L) and Proteins (P) utilized during
indirect calorimetry examination. These values were calculated from
respiratory quotients and urine nitrogen measurement (Livesey and
Elia, 1988) Mean values in men (left) and women (right) are
reported.
FIGURE 3 | CollagenVI myopathies: FFM metabolism. (Left) Linear
correlation between FFM in kg and percentage of carbohydrates used as
metabolic substrate (correlation coefficient R=0.89 e P <0.01), and (right)
correlation between FFM and percentage of lipids used as metabolic
substrate (correlation coefficient R=−0.87 e P =0.01). White dots represent
men and black dots represent women. The percentage of substrate utilized
was calculated using the respiratory quotient and urinary urea nitrogen
(Livesey and Elia, 1988). Data from one BM were missing.
FIGURE 4 | Muscle strength and functional body composition. As expected there was no correlation between Megascore and REE/FM, but instead a
strong correlation between Megascore and the REE/FFM ratio (R=−0.94, P <0.001) (right).
with the new concept of functional body composition (Müller
et al., 2009).
COL6-RM patients showed a REE, analyzed by indirect
calorimetry, in the range of normality, despite the severe reduction
of the FFM. Predictive formulas estimate REE values in line with
what we actually have found by indirect calorimetry. Applying
the concept of functional body composition and relating FFM to
energy expenditure, we found a clear deviation from normality
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FIGURE 5 | Muscle strength and body composition. Correlation between
appendicular LM (A) and Trunk LM (B) with the Megascore [respectively for
limbs and trunk, R=0.87 (P <0.01) and R=0.80 (P <0.05)]. (C) Correlation
between total FFM in kg and Megascore (R=0.84, P <0.01).
(metabolic disequilibrium) with a considerably augmented REE
per kilogram of FFM. Our assumptions are supported by the fact
that REE, estimated through FFM-based equations, clearly under-
estimate the effective metabolism of these patients by 25–30%
(Figure 1).
If we compare the metabolism predicted by FFM-based-
formulas with the values of REE, adjusted for body composition,
we find that the FFM of these patients is overworking or in a hyper-
metabolic state (Müller, 2007). A similar metabolic alteration has
been reported by Zanardi et al. in Duchenne patients (Zanardi
FIGURE 6 | Muscle strength and creatinine. (A) Correlation between
Megascore and blood creatinine (R=0.94, P = 0.001), or (B) urine
creatinine (UC) (R=0.95, P <0.001). (C) Correlation between Megascore
and CHI (Rosenfalck et al., 1994) (R=0.93, P =0.001).
et al., 2003b). It has been considered an enduring enigma: why
is the ratio of REE to metabolically active tissue mass, expressed
as the REE/FFM ratio, greater in magnitude in subjects with a
small FFM than in subjects with a large FFM? (Heymsfield et al.,
2002).
In COL6-RM patients, FFM requires more energy than in
healthy subjects, and because FFM is made up of muscle and
internal organs, we can only speculate as to which of these two
components presents a hypermetabolic state. In particular, the
augmented REE/FFM ratio could be due to a non-physiological
increase in visceral organ metabolism, or to an altered energy
expenditure of muscle cells. However, even if our study cannot
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completely answer this question, all evidence suggests that the
second hypothesis is the right one.
If we consider the pathological alteration of muscle structures,
underlined in mouse model studies (De Palma et al., 2013), with
the loss of muscular protein stability leads to a loss of efficiency,
and additional energy is necessary to maintain muscle cell home-
ostasis. Even if this theory has been demonstrated in other studies
no one had ever pointed out that this behavior is strictly correlated
with the severity of the disease. Our hypothesis is that, in a dys-
trophic environment, the energy that the muscle has to spend in
order to maintain its function is inversely proportional to the total
muscular mass. Moreover, if the augmented REE/FFM were due
to an increased metabolism of the visceral organs, we should have
found some alterations in bio-humoral parameters (Gelfand et al.,
1987; Izamis et al., 2012). On the contrary COL6-RM subjects do
not show any important variation in blood or urine biochemical
assays.
Additionally, there was no correlation between the REE/FM
and the clinical status portrayed by Megascore analysis (Figure 4).
Therefore,we can exclude increased adipocytes energy expenditure
as a source of the hypermetabolic state.
Finally, recent discoveries about mitochondrial metabolism
(Bernardi and Bonaldo, 2008; Shaham et al., 2010) offer a possible
biochemical explanation of the increased REE/FFM ratio. In par-
ticular, Bernardi et al. have found important alterations in mito-
chondrial membrane permeability due to the ColA6 mutation.
The lack of Collagen VI causes increased transient openings of
the Permeability Transition Pore ion channel in the mitochondrial
inner membrane, with consequent mitochondrial depolarization
and energy dissipation. This leads to a switch of the ATP synthase
into an ATP hydrolase with a progressive impairment of respira-
tion which may be responsible for the augmented REE spent by
the muscular mass. This pathophysiology mechanism may explain
our findings.
We also discovered that the metabolic substrates consumed by
these patients are strictly related to their FFM (Figures 2 and 3).
In particular, patients with higher FFM have a carbohydrate-based
metabolism, while the ones with lower FFM prevalently use fatty
acids as metabolic substrates. These findings suggest that patients
with a relatively greater FFM have more muscular mass, and con-
sequently an increased glycogen reserve to be used, compared to
patients with lower FFM (Tsujino et al., 2000). On the other hand,
the fat-based metabolism is explained by the increasing fat infil-
tration with disease progression; the depletion of muscular mass
and the correlated decrement in glycogen storage lead to a meta-
bolic shift toward burning fatty acids, whose reserves increase and
infiltrate muscular tissue (Tagliavini et al., 2014). These evidences
suggest that the worsening of the pathology is closely correlated to
important changes in muscle metabolism.
Another significant result is the correlation between FFM and
muscle strength, summarized by the Megascore (Figure 5). Other
studies have previously demonstrated that Megascore is a good
indicator of patients’ muscular efficiency, paralleling muscle func-
tion (Merlini et al., 2002, 2004). Hence, the correlation between
muscle Megascore and FFM is more a portrait of the muscu-
lar mass and its efficiency, rather than of visceral organ activity.
The strong correlations between Megascore and appendicular LM,
where the non-muscle component of FFM is minimal, support this
hypothesis.
This is a perfect expression of the concept of functional body
composition: in COL6-RM, a pure body composition parameter
like appendicular LM is directly correlated to muscular strength
(Megascore) and contributes to the diagnosis of sarcopenia, a con-
dition in which the loss of skeletal muscle mass is associated with
lower muscle strength and function (Abellan Baumgartner et al.,
1998; van Kan et al., 2012)
Creatinine is derived from the metabolism of creatine, which
is transformed into phosphocreatine and used by muscles as an
energetic substrate (Hoagland et al., 1945). A higher production
of creatinine is linked to a higher use of phosphocreatine and, con-
sequently, to greater muscular efficiency. In order to confirm this
hypothesis, and to exclude any artifact due to individual body
composition, we have analyzed the CHI, which evaluates uri-
nary creatinine levels by normalizing the individual differences
among subjects (Rosenfalck et al., 1994). Even in this case, the
CHI scores perfectly correlate to the muscle strength, as evaluated
by Megascore (Figure 6).
Hence, even if Franciotta et al. (2003) declare that urinary
creatinine is not a good predictive indicator of skeletal muscu-
lar mass in Duchenne dystrophy; our results suggest that it is a
good indicator of muscular performance.
Another important correlation is the one between blood crea-
tinine and Megascore. Even if we have to consider renal filtration,
blood creatinine gives an instant picture of the muscle metabo-
lism (Baxmann et al., 2008). The probability of finding circulating
creatinine is directly proportional to the quantity of phospho-
creatine produced and used by muscle cells. Considering our
results about urinary creatinine and CHI, this finding confirms
the previous ones.
All in all, in this study, we have pointed out the importance
of a nutritional approach to genetically based pathologies, such
as UCMD and BM diseases. Additionally, we have underlined the
necessity of a functional body composition analysis, which could
be a powerful clinical tool for patients’ follow-up and prognosis.
The main limit of our study is represented by the scant num-
ber of recruited patients, caused by the rarity of these pathologies;
hence, our conclusions should be confirmed by the analysis of a
wider sample of subjects.
Our results confirm and complete what has been reported in
the literature about collagen VI myopathies, further supporting
the rationale for nutritional interventions aimed at correcting the
metabolic imbalance and maintaining the patient’s muscular mass.
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